HKG:6132

4 stories mentioning HKG:6132Updated 51d ago

Every FINWIRES story that references HKG:6132, newest first.

Hong Kong Stocks Slide; Senior Technology Gains as HJ Science Flops in Debut

Hong Kong stocks declined on Tuesday as investors assessed the latest developments in U.S.-Iran negotiations while bracing for a more hawkish Federal Reserve.The Hang Seng Index fell 1.8%, or 432.24 points, to close at 23,336.28. The Hang Seng China Enterprises Index dropped 2.0%, or 155.38 points, to finish at 7,759.36.The United States waived sanctions on Iran for 60 days beginning Monday following an initial round of talks under a fledgling peace agreement.U.S. President Donald Trump said he would "do what I have to do" if Tehran failed to uphold its commitments.Meanwhile, traders are increasingly betting on a faster pace of monetary tightening under new Federal Reserve Chair Kevin Warsh.Markets expect the Fed to deliver a total of 50 basis points of rate hikes by year-end to combat inflation pressures, particularly from higher energy costs, Reuters reported, citing CME Group's FedWatch Tool.In corporate news, two companies made their trading debut on the Hong Kong bourse.HJ Science (HKG:6132) closed 57% lower at HK$35.26, compared with its offer price of HK$81.80.Shenzhen Senior Technology Material (HKG:6067, SHE:300568) advanced 22% to HK$11.00, versus its offer price of HK$8.98.

Hang SengHKG:6067HKG:6132SHE:300568

Asia52d ago

HJ Science Makes Tepid Hong Kong Debut as Shares Open Flat

HJ Science (HKG:6132) saw a tepid stock market debut as its shares opened flat on their maiden trading in Hong Kong Tuesday morning.The clinical-stage biotech company opened at HK$81.80 per share, unchanged from its IPO price.

HKG:6132

Asia52d ago

HJ Science Nets HK$1 Billion in Hong Kong IPO Ahead of Debut

HJ Science (HKG:6132) raised HK$1.02 billion in net proceeds from its initial public offering in Hong Kong, according to a Monday after-market filing with the Hong Kong Exchange.The clinical-stage biotech company priced its IPO at HK$81.80 per share, issuing 13.6 million shares in total.The Hong Kong public offering portion of the deal was 2,007.6 times subscribed, with a final allotment of 1.36 million shares.The international offering was 7 times subscribed, with 12.2 million shares allocated.Cornerstone investors received 6.2 million shares, representing 45.79% of the IPO shares.HJ Science is set to debut on the Hong Kong bourse today, June 23.

HKG:6132

Asia63d ago

HJ Science Launches HK$1.11 Billion Hong Kong IPO

HJ Science (HKG:6132) launched its Hong Kong initial public offering on Friday, seeking to raise HK$1.11 billion.The Chinese biotechnology company is offering 13.6 million H shares at an indicative price of HK$81.80 per share, according to a Hong Kong bourse filing.The offering comprises around 1.4 million shares for Hong Kong investors and 12.2 million shares for international investors, subject to reallocation.The IPO's allocation results are due June 22, ahead of the company's planned trading debut on June 23.Net proceeds will be used primarily to advance the company's clinical research and development activities.The company secured six cornerstone investors, including Foresight Fund, that committed to subscribe to $65 million worth of IPO shares.Citic Securities is the sole coordinator of the IPO.

HKG:6132

Track with the FINWIRES app suite

FolioX

Track HKG:6132 in your portfolio

WheelAI

Analyze HKG:6132 options with the wheel strategy

StockInsider

See market sentiment on HKG:6132